Plant Polyphenols as Dietary Modulators of Brain Functions

Polyphenols in Human Health and Disease

Volumn 1, Issue , 2013, Pages 357-370

  Vauzour, David ^a   Kerr, Jason ^a   Czank, Charles ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b LEATHERHEAD FOOD RESEARCH   (United Kingdom)

Author keywords

Brain; Cognitive function; Neuroinflammation; Neuroprotection; Polyphenols; Signaling pathways; Transcription factors

Indexed keywords

EID: 84902571590     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-398456-2.00027-X     Document Type: Chapter

References (184)

1. Aquilano K., Baldelli S., Rotilio G., Ciriolo M.R. Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols. Neurochem Res 2008, 33(12):2416-2426.
2. Lau F.C., Bielinski D.F., Joseph J.A. Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. J Neurosci Res 2007, 85(5):1010-1017.
3. Spencer J.P. Flavonoids: modulators of brain function?. Br J Nutr 2008, 99(E Suppl. 1):ES60-ES77.
4. Spencer J.P., Vafeiadou K., Williams R.J., Vauzour D. Neuroinflammation: modulation by flavonoids and mechanisms of action. Mol Aspects Med 2012, 33(1):83-97.
5. Vauzour D., Vafeiadou K., Rodriguez-Mateos A., Rendeiro C., Spencer J.P. The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr 2008, 3(3-4):115-126.
6. Vauzour D., Ravaioli G., VafeiAdou K., Rodriguez-Mateos A., Angeloni C., Spencer J.P. Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols. Arch Biochem Biophys 2008, 476(2):145-151.
7. Vafeiadou K., Vauzour D., Spencer J.P. Neuroinflammation and its modulation by flavonoids. Endocr Metab Immune Disord Drug Targets 2007, 7(3):211-224.
8. Spencer J.P., Vauzour D., Rendeiro C. Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects. Arch Biochem Biophys 2009, 492(1-2):1-9.
9. Chan Y.C., Hosoda K., Tsai C.J., Yamamoto S., Wang M.F. Favorable effects of tea on reducing the cognitive deficits and brain morphological changes in senescence-accelerated mice. J Nutr Sci Vitaminol (Tokyo) 2006, 52(4):266-273.
10. Haque A.M., Hashimoto M., Katakura M., Tanabe Y., Hara Y., Shido O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 2006, 136(4):1043-1047.
11. Kaur T., Pathak C.M., Pandhi P., Khanduja K.L. Effects of green tea extract on learning, memory, behavior and acetylcholinesterase activity in young and old male rats. Brain Cogn 2008, 67(1):25-30.
12. Oliveira D.R., Sanada P.F., Saragossa Filho A.C., Innocenti L.R., Oler G., Cerutti J.M., et al. Neuromodulatory property of standardized extract Ginkgo biloba L. (EGb 761) on memory: behavioral and molecular evidence. Brain Res 2009, 1269:68-89.
13. Shif O., Gillette K., Damkaoutis C.M., Carrano C., Robbins S.J., Hoffman J.R. Effects of Ginkgo biloba administered after spatial learning on water maze and radial arm maze performance in young adult rats. Pharmacol Biochem Behav 2006, 84(1):17-25.
14. Field D.T., Williams C.M., Butler L.T. Consumption of cocoa flavanols results in an acute improvement in visual and cognitive functions. Physiol Behav 2011, 103(3-4):255-260.
15. Scholey A.B., French S.J., Morris P.J., Kennedy D.O., Milne A.L., Haskell C.F. Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J Psychopharmacol 2010, 24(10):1505-1514.
16. Casadesus G., Shukitt-Hale B., Stellwagen H.M., Zhu X., Lee H.G., Smith M.A., et al. Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 2004, 7(5-6):309-316.
17. Shukitt-Hale B., Lau F.C., Carey A.N., Galli R.L., Spangler E.L., Ingram D.K., et al. Blueberry polyphenols attenuate kainic acid-induced decrements in cognition and alter inflammatory gene expression in rat hippocampus. Nutr Neurosci 2008, 11(4):172-182.
18. Williams C.M., El Mohsen M.A., Vauzour D., Rendeiro C., Butler L.T., Ellis J.A., et al. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic Biol Med 2008, 45(3):295-305.
19. Krikorian R., Shidler M.D., Nash T.A., Kalt W., Vinqvist-Tymchuk M.R., Shukitt-Hale B., et al. Blueberry supplementation improves memory in older adults. J Agric Food Chem 2010, 58(7):3996-4000.
20. Assuncao M., Santos-Marques M.J., Carvalho F., Lukoyanov N.V., Andrade J.P. Chronic green tea consumption prevents age-related changes in rat hippocampal formation. Neurobiol Aging 2011, 32(4):707-717.
21. Assuncao M., Santos-Marques M.J., de Freitas V., Carvalho F., Andrade J.P., Lukoyanov N.V., et al. Red wine antioxidants protect hippocampal neurons against ethanol-induced damage: a biochemical, morphological and behavioral study. Neuroscience 2007, 146(4):1581-1592.
22. Datla K.P., Christidou M., Widmer W.W., Rooprai H.K., Dexter D.T. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport 2001, 12(17):3871-3875.
23. Bastianetto S., Zheng W.H., Quirion R. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol 2000, 131(4):711-720.
24. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic Biol Med 2004, 36(7):838-849.
25. Calabrese V., Cornelius C., Dinkova-Kostova A.T., Iavicoli I., Di Paola R., Koverech A., et al. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim Biophys Acta 2011, 1822(5):753-783.
26. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79(5):727-747.
27. Crozier A., Jaganath I.B., Clifford M.N. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 2009, 26(8):1001-1043.
28. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81(1 Suppl.):230S-242S.
29. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005, 81(1 Suppl.):243S-255S.
30. Grassi D., Desideri G., Croce G., Tiberti S., Aggio A., Ferri C. Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des 2009, 15(10):1072-1084.
31. Wang Y., Ho C.T. Metabolism of flavonoids. Forum Nutr 2009, 61:64-74.
32. Winter J., Moore L.H., Dowell V.R., Bokkenheuser V.D. C-ring cleavage of flavonoids by human intestinal bacteria. Appl Environ Microbiol 1989, 55(5):1203-1208.
33. Walle T., Browning A.M., Steed L.L., Reed S.G., Walle U.K. Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr 2005, 135(1):48-52.
34. Liu Y., Hu M. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab Dispos 2002, 30(4):370-377.
35. Chen Y., Wang J., Jia X., Tan X., Hu M. Role of intestinal hydrolase in the absorption of prenylated flavonoids present in Yinyanghuo. Molecules 2011, 16(2):1336-1348.
36. Nemeth K., Plumb G.W., Berrin J.G., Juge N., Jacob R., Naim H.Y., et al. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr 2003, 42(1):29-42.
37. Maestro A., Terdoslavich M., Vanzo A., Kuku A., Tramer F., Nicolin V., et al. Expression of bilitranslocase in the vascular endothelium and its function as a flavonoid transporter. Cardiovasc Res 2010, 85(1):175-183.
38. Brand W., Schutte M.E., Williamson G., van Zanden J.J., Cnubben N.H., Groten J.P., et al. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed Pharmacother 2006, 60(9):508-519.
39. Kay C.D. Aspects of anthocyanin absorption, metabolism and pharmacokinetics in humans. Nutr Res Rev 2006, 19(1):137-146.
40. Sanchez-Patan F., Tabasco R., Monagas M., Requena T., Pelaez C., Moreno-Arribas M.V., et al. Capability of Lactobacillus plantarum IFPL935 to catabolize flavan-3-ol compounds and complex phenolic extracts. J Agric Food Chem 2012, 60(29):7142-7151.
41. van Duynhoven J., Vaughan E.E., Jacobs D.M., Kemperman R.A., van Velzen E.J., Gross G., et al. Metabolic fate of polyphenols in the human superorganism. Proc Natl Acad Sci USA 2011, 108(Suppl. 1):4531-4538.
42. McGhie T.K., Walton M.C. The bioavailability and absorption of anthocyanins: towards a better understanding. Mol Nutr Food Res 2007, 51(6):702-713.
43. Bò C.D., Ciappellano S., Klimis-Zacas D., Martini D., Gardana C., Riso P., et al. Anthocyanin absorption, metabolism, and distribution from a wild blueberry-enriched diet (Vaccinium angustifolium) is affected by diet duration in the Sprague-Dawley rat. J Agric Food Chem 2009, 58(4):2491-2497.
44. Nurmi T., Mursu J., Heinonen M., Nurmi A., Hiltunen R., Voutilainen S. Metabolism of berry anthocyanins to phenolic acids in humans. J Agric Food Chem 2009, 57(6):2274-2281.
45. 13C- tracer study. Am J Clin Nutr 2013, 97(5):995-1003.
46. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol Dis 2010, 37(1):13-25.
47. Faria A., Mateus N., Calhau C. Flavonoid transport across blood-brain barrier: implication for their direct neuroprotective actions. Nutrition and Aging 2012, 1(2):89-97.
48. Youdim K.A., Dobbie M.S., Kuhnle G., Proteggente A.R., Abbott N.J., Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 2003, 85(1):180-192.
49. Youdim K.A., Qaiser M.Z., Begley D.J., Rice-Evans C.A., Abbott N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004, 36(5):592-604.
50. Faria A., Pestana D., Teixeira D., Couraud P.O., Romero I., Weksler B., et al. Insights into the putative catechin and epicatechin transport across blood-brain barrier. Food Funct 2011, 2(1):39-44.
51. Peng H.W., Cheng F.C., Huang Y.T., Chen C.F., Tsai T.H. Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. J Chromatog B Biomed Sci Appl 1998, 714(2):369-374.
52. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998, 19(10):1771-1776.
53. Abd El Mohsen M.M., Kuhnle G., Rechner A.R., Schroeter H., Rose S., Jenner P., et al. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 2002, 33(12):1693-1702.
54. El Mohsen M.A., Marks J., Kuhnle G., Moore K., Debnam E., Kaila Srai S., et al. Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br J Nutr 2006, 95(1):51-58.
55. Talavera S., Felgines C., Texier O., Besson C., Gil-Izquierdo A., Lamaison J.L., et al. Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J Agric Food Chem 2005, 53(10):3902-3908.
56. Friden M., Ljungqvist H., Middleton B., Bredberg U., Hammarlund-Udenaes M. Improved measurement of drug exposure in the brain using drug-specific correction for residual blood. J Cereb Blood Flow Metab 2010, 30(1):150-161.
57. Schaffer S., Halliwell B. Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes Nutr 2012, 7(2):99-109.
58. Passamonti S., Vrhovsek U., Vanzo A., Mattivi F. Fast access of some grape pigments to the brain. J Agric Food Chem 2005, 53(18):7029-7034.
59. Kalt W., Blumberg J.B., McDonald J.E., Vinqvist-Tymchuk M.R., Fillmore S.A., Graf B.A., et al. Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. J Agric Food Chem 2008, 56(3):705-712.
60. Milbury P.E., Kalt W. Xenobiotic metabolism and berry flavonoid transport across the blood-brain barrier. J Agric Food Chem 2010, 58(7):3950-3956.
61. 14C-labeled grape polyphenols in the periphery and the central nervous system following oral administration. J Med Food 2010, 13(4):926-933.
62. Commenges D., Scotet V., Renaud S., Jacqmin-Gadda H., Barberger-Gateau P., Dartigues J.F. Intake of flavonoids and risk of dementia. Eur J Epidemiol 2000, 16(4):357-363.
63. Nurk E., Refsum H., Drevon C.A., Tell G.S., Nygaard H.A., Engedal K., et al. Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr 2009, 139(1):120-127.
64. Beking K., Vieira A. Flavonoid intake and disability-adjusted life years due to Alzheimer's and related dementias: a population-based study involving twenty-three developed countries. Public Health Nutr 2010, 13(9):1403-1409.
65. Letenneur L., Proust-Lima C., Le Gouge A., Dartigues J.F., Barberger-Gateau P. Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol 2007, 165(12):1364-1371.
66. Kesse-Guyot E., Fezeu L., Andreeva V.A., Touvier M., Scalbert A., Hercberg S., et al. Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later. J Nutr 2012, 142(1):76-83.
67. Barberger-Gateau P., Raffaitin C., Letenneur L., Berr C., Tzourio C., Dartigues J.F., et al. Dietary patterns and risk of dementia: the three-city cohort study. Neurology 2007, 69(20):1921-1930.
68. Gajewski A., Hensch SA Gingko biloba and memory for a maze. Psychol Rep 1999, 84(2):481-484.
69. Itil T.M., Eralp E., Ahmed I., Kunitz A., Itil K.Z. The pharmacological effects of Gingko biloba, a plant extract, on the brain of dementia patients in comparinson with tacrine. Psychopharmacol Bull 1998, 34(3):391-396.
70. Walesiuk A., Trofimiuk E., Braszko J.J. Ginkgo biloba normalizes stress- and corticosterone-induced impairment of recall in rats. Pharmacol Res 2006, 53(2):123-128.
71. Hoffman J.R., Donato A., Robbins S.J. Ginkgo biloba promotes short-term retention of spatial memory in rats. Pharmacol Biochem Behav 2004, 77(3):533-539.
72. Oyama Y., Chikahisa L., Ueha T., Kanemaru K., Noda K. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res 1996, 712(2):349-352.
73. 2+-loaded brain neurons. Brain Res 1994, 635(1-2):125-129.
74. Stoll S., Scheuer K., Pohl O., Muller W.E. Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiatry 1996, 29(4):144-149.
75. Chopin P., Briley M. Effects of four non-cholinergic cognitive enhancers in comparinson with tacrine and galanthamine on scopolamine-induced amnesia in rats. Psychopharmacol Bull 1992, 106(1):26-30.
76. Ramassamy C., Clostre F., Christen Y., Costentin J. Prevention by a Ginkgo biloba extract (GBE 761) of the dopaminergic neurotoxicity of MPTP. J Pharm Pharmacol 1990, 42(11):785-789.
77. Joseph J.A., Shukitt-Hale B., Denisova N.A., Bielinski D., Martin A., McEwen J.J., et al. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 1999, 19(18):8114-8121.
78. Crews W.D., Harrison D.W., Griffin M.L., Addison K., Yount A.M., Giovenco M.A., et al. A double-blinded, placebo-controlled, randomized trial of the neuropsychologic efficacy of cranberry juice in a sample of cognitively intact older adults: pilot study findings. J Altern Complement Med 2005, 11(2):305-309.
79. Krikorian R., Nash T.A., Shidler M.D., Shukitt-Hale B., Joseph J.A. Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br J Nutr 2010, 103(5):730-734.
80. Goyarzu P., Malin D.H., Lau F.C., Taglialatela G., Moon W.D., Jennings R., et al. Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci 2004, 7(2):75-83.
81. Barros D., Amaral O.B., Izquierdo I., Geracitano L., do Carmo Bassols Raseira M., Henriques A.T., et al. Behavioral and genoprotective effects of Vaccinium berries intake in mice. Pharmacol Biochem Behav 2006, 84(2):229-234.
82. Ramirez M.R., Izquierdo I., do Carmo Bassols Raseira M., Zuanazzi J.A., Barros D., Henriques A.T. Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol Res 2005, 52(6):457-462.
83. Burke S.N., Barnes C.A. Neural plasticity in the ageing brain. Nat Rev Neurosci 2006, 7(1):30-40.
84. Stangl D., Thuret S. Impact of diet on adult hippocampal neurogenesis. Genes Nutr 2009, 4(4):271-282.
85. Hartman R.E., Shah A., Fagan A.M., Schwetye K.E., Parsadanian M., Schulman R.N., et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis 2006, 24(3):506-515.
86. Pu F., Mishima K., Irie K., Motohashi K., Tanaka Y., Orito K., et al. Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J Pharmacol Sci 2007, 104(4):329-334.
87. Maher P., Akaishi T., Abe K. Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci USA 2006, 103(44):16568-16573.
88. van Praag H., Lucero M.J., Yeo G.W., Stecker K., Heivand N., Zhao C., et al. Plant-derived flavanol (-)epicatechin enhances angiogenesis and retention of spatial memory in mice. J Neurosci 2007, 27(22):5869-5878.
89. Schroeter H., Heiss C., Balzer J., Kleinbongard P., Keen C.L., Hollenberg N.K., et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 2006, 103(4):1024-1029.
90. Heiss C., Dejam A., Kleinbongard P., Schewe T., Sies H., Kelm M. Vascular effects of cocoa rich in flavan-3-ols. JAMA 2003, 290(8):1030-1031.
91. Heiss C., Finis D., Kleinbongard P., Hoffmann A., Rassaf T., Kelm M., et al. Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol 2007, 49(2):74-80.
92. Sorond F.A., Lipsitz L.A., Hollenberg N.K., Fisher N.D. Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat 2008, 4(2):433-440.
93. Francis S.T., Head K., Morris P.G., Macdonald I.A. The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 2006, 47(Suppl. 2):S215-20.
94. Gage F.H. Mammalian neural stem cells. Science 2000, 287(5457):1433-1438.
95. Zhao C., Deng W., Gage F.H. Mechanisms and functional implications of adult neurogenesis. Cell 2008, 132(4):645-660.
96. Palmer T.D., Willhoite A.R., Gage F.H. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000, 425(4):479-494.
97. Checkoway H., Powers K., Smith-Weller T., Franklin G.M., Longstreth W.T., Swanson P.D. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 2002, 155(8):732-738.
98. Levites Y., Youdim M.B., Maor G., Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-κB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 2002, 63(1):21-29.
99. Levites Y., Weinreb O., Maor G., Youdim M.B., Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 2001, 78(5):1073-1082.
100. Spencer J.P.E., Whiteman M., Jenner P., Halliwell B. 5-S-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. J Neurochem 2002, 81(1):122-129.
101. Vauzour D., Corona G., Spencer J.P. Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. Arch Biochem Biophys 2010, 501(1):106-111.
102. Vauzour D., Vafeiadou K., Spencer J.P. Inhibition of the formation of the neurotoxin 5-S-cysteinyl-dopamine by polyphenols. Biochem Biophys Res Commun 2007, 362(2):340-346.
103. Li H., Dryhurst G. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the pyruvate dehydrogenase complex. J Neural Transm 2001, 108(12):1363-1374.
104. Walsh D.M., Selkoe D.J. Aβ oligomers - a decade of discovery. J Neurochem 2007, 101(5):1172-1184.
105. Yan J.J., Cho J.Y., Kim H.S., Kim K.L., Jung J.S., Huh S.O., et al. Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol 2001, 133(1):89-96.
106. Rezai-Zadeh K., Arendash G.W., Hou H., Fernandez F., Jensen M., Runfeldt M., et al. Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res 2008, 1214:177-187.
107. Ono K., Condron M.M., Ho L., Wang J., Zhao W., Pasinetti G.M., et al. Effects of grape seed-derived polyphenols on amyloid β-protein self-assembly and cytotoxicity. J Biol Chem 2008, 283(47):32176-32187.
108. Hirohata M., Hasegawa K., Tsutsumi-Yasuhara S., Ohhashi Y., Ookoshi T., Ono K., et al. The anti-amyloidogenic effect is exerted against Alzheimer's β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 2007, 46(7):1888-1899.
109. Onozuka H., Nakajima A., Matsuzaki K., Shin R.W., Ogino K., Saigusa D., et al. Nobiletin, a citrus flavonoid, improves memory impairment and Aβ pathology in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther 2008, 326(3):739-744.
110. Fernandez J.W., Rezai-Zadeh K., Obregon D., Tan J. EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP. FEBS Lett 2010, 584(19):4259-4267.
111. Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 2005, 25(38):8807-8814.
112. Mandel S.A., Amit T., Kalfon L., Reznichenko L., Weinreb O., Youdim M.B. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J Alzheimers Dis 2008, 15(2):211-222.
113. Amit T., Avramovich-Tirosh Y., Youdim M.B., Mandel S. Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators. FASEB J 2008, 22(5):1296-1305.
114. Ehrnhoefer D.E., Bieschke J., Boeddrich A., Herbst M., Masino L., Lurz R., et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 2008, 15(6):558-566.
115. Mori T., Rezai-Zadeh K., Koyama N., Arendash G.W., Yamaguchi H., Kakuda N., et al. Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. J Biol Chem 2012, 287(19):6912-6927.
116. Williams R.J., Spencer J.P. Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol Med 2012, 52(1):35-45.
117. Hirsch E.C., Hunot S., Hartmann A. Neuroinflammatory processes in Parkinson's disease. Parkinsonism Relat Disord 2005, 11(Suppl. 1):S9-S15.
118. Agostinho P., Cunha R.A., Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des 2010, 16(25):2766-2778.
119. Pratico D., Trojanowski J.Q. Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?. Neurobiol Aging 2000, 21(3):441-445.
120. Ceulemans A.G., Zgavc T., Kooijman R., Hachimi-Idrissi S., Sarre S., Michotte Y. The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation 2010, 7:74.
121. Stewart V.C., Heales S.J. Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration. Free Radic Biol Med 2003, 34(3):287-303.
122. Moncada S., Bolanos J.P. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 2006, 97(6):1676-1689.
123. Qin L., Liu Y., Wang T., Wei S.J., Block M.L., Wilson B., et al. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 2004, 279(2):1415-1421.
124. Bal-Price A., Matthias A., Brown G.C. Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J Neurochem 2002, 80(1):73-80.
125. Abramov A.Y., Jacobson J., Wientjes F., Hothersall J., Canevari L., Duchen M.R. Expression and modulation of an NADPH oxidase in mammalian astrocytes. J Neurosci 2005, 25(40):9176-9184.
126. Brown G.C., Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 2003, 27(3):325-355.
127. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 2002, 14(6):477-492.
128. Taylor D.L., Jones F., Kubota E.S., Pocock J.M. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor α-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 2005, 25(11):2952-2964.
129. Szekely C.A., Thorne J.E., Zandi P.P., Ek M., Messias E., Breitner J.C., et al. Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 2004, 23(4):159-169.
130. González-Gallego J., García-Mediavilla M.V., Sánchez-Campos S., Tuñón M.J. Fruit polyphenols, immunity and inflammation. Br J Nutr 2010, 104(Suppl. S3):S15-S27.
131. Kao T.K., Ou Y.C., Raung S.L., Lai C.Y., Liao S.L., Chen C.J. Inhibition of nitric oxide production by quercetin in endotoxin cytokine-stimulated microglia. Life Sci 2010, 86(9-10):315-321.
132. Chen C.Y., Jang J.H., Li M.H., Surh Y.J. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 2005, 331(4):993-1000.
133. Sharma V., Mishra M., Ghosh S., Tewari R., Basu A., Seth P., et al. Modulation of interleukin-1β mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res Bull 2007, 73(1-3):55-63.
134. Bureau G., Longpre F., Martinoli M.G. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res 2008, 86(2):403-410.
135. Vafeiadou K., Vauzour D., Lee H.Y., Rodriguez-Mateos A., Williams R.J., Spencer J.P. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 2009, 484(1):100-109.
136. Steffen Y., Gruber C., Schewe T., Sies H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 2008, 469(2):209-219.
137. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006, 97(6):1634-1658.
138. Pannala A.S., Rice-Evans C.A., Halliwell B., Singh S. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem Biophys Res Commun 1997, 232(1):164-168.
139. Russo A., Acquaviva R., Campisi A., Sorrenti V., Di Giacomo C., Virgata G., et al. Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors. Cell Biol Toxicol 2000, 16(2):91-98.
140. Visioli F., Bellomo G., Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 1998, 247(1):60-64.
141. Schroeter H., Bahia P., Spencer J.P.E., Sheppard O., Rattray M., Rice-Evans C., et al. (-)-epicatechin stimulates ERK-dependent cyclic AMP response element activity and upregulates GLUR2 in cortical neurons. J Neurochem 2007, 101(6):606-1596.
142. Schroeter H., Spencer J.P., Rice-Evans C., Williams R.J. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 2001, 358(Pt 3):547-557.
143. Vauzour D., VafeiAdou K., Rice-Evans C., Williams R.J., Spencer J.P. Activation of pro-survival Akt and ERK1 2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 2007, 103(4):1355-1367.
144. Mattson M.P., Cheng A. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci 2006, 29(11):632-639.
145. Calabrese E.J. Neuroscience and hormesis: overview and general findings. Crit Rev Toxicol 2008, 38(4):249-252.
146. Kraft A.D., Johnson D.A., Johnson J.A. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 2004, 24(5):1101-1112.
147. Lee J.M., Johnson J.A. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol 2004, 37(2):139-143.
148. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999, 13(1):76-86.
149. Nguyen T., Sherratt P.J., Pickett C.B. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol 2003, 43:233-260.
150. Ren J., Fan C., Chen N., Huang J., Yang Q. Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem Res 2011, 36(12):2352-2362.
151. Kurauchi Y., Hisatsune A., Isohama Y., Mishima S., Katsuki H. Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving heme oxygenase-1 and brain-derived neurotrophic factor. Br J Pharmacol 2012, 166(3):1151-1168.
152. Scapagnini G., Butterfield D.A., Colombrita C., Sultana R., Pascale A., Calabrese V. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid Redox Signal 2004, 6(5):811-818.
153. Shah Z.A., Li R.C., Ahmad A.S., Kensler T.W., Yamamoto M., Biswal S., et al. The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway. J Cereb Blood Flow Metab 2010, 30(12):1951-1961.
154. Bahia P.K., Rattray M., Williams R.J. Dietary flavonoid(-)epicatechin stimulates phosphatidylinositol 3-kinase-dependent anti-oxidant response element activity and up-regulates glutathione in cortical astrocytes. J Neurochem 2008, 106(5):2194-2204.
155. Impey S., Smith D.M., Obrietan K., Donahue R., Wade C., Storm D.R. Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci 1998, 1(7):595-601.
156. Bourtchuladze R., Frenguelli B., Blendy J., Cioffi D., Schutz G., Silva A.J. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994, 79(1):59-68.
157. Finkbeiner S. CREB couples neurotrophin signals to survival messages. Neuron 2000, 25(1):11-14.
158. Tully T., Bourtchouladze R., Scott R., Tallman J. Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov 2003, 2(4):267-277.
159. Finkbeiner S., Tavazoie S.F., Maloratsky A., Jacobs K.M., Harris K.M., Greenberg M.E. CREB: a major mediator of neuronal neurotrophin responses. Neuron 1997, 19(5):1031-1047.
160. Kong A.N., Yu R., Chen C., Mandlekar S., Primiano T. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res 2000, 23(1):1-16.
161. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994, 269(7):5241-5248.
162. Schratt G.M., Nigh E.A., Chen W.G., Hu L., Greenberg M.E. BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J Neuroscience 2004, 24(33):7366-7377.
163. Yin Y., Edelman G.M., Vanderklish P.W. The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes. Proc Natl Acad Sci USA 2002, 99(4):2368-2373.
164. 2+ and cAMP requires protein kinase A and mitogen-activated protein kinase/extracellular regulated kinase activation. J Neuroscience 2001, 21(15):5484-5493.
165. Levites Y., Amit T., Youdim M.B., Mandel S. Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol(-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 2002, 277(34):30574-30580.
166. Ito H., Sun X.L., Watanabe M., Okamoto M., Hatano T. Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells. Biosci Biotechnol Biochem 2008, 72(3):885-888.
167. Reznichenko L., Amit T., Youdim M.B., Mandel S. Green tea polyphenol(-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J Neurochem 2005, 93(5):1157-1167.
168. Camandola S., Mattson M.P. NF-κB as a therapeutic target in neurodegenerative diseases. Expert Opin Ther Targets 2007, 11(2):123-132.
169. Zhang F., Qian L., Flood P.M., Shi J.S., Hong J.S., Gao H.M. Inhibition of I κB kinase-β protects dopamine neurons against lipopolysaccharide-induced neurotoxicity. J Pharmacol Exp Ther 2010, 333(3):822-833.
170. Liang Y.C., Huang Y.T., Tsai S.H., Lin-Shiau S.Y., Chen C.F., Lin J.K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 1999, 20(10):1945-1952.
171. Huang Q., Wu L.J., Tashiro S., Gao H.Y., Onodera S., Ikejima T. (+)-Catechin, an ingredient of green tea, protects murine microglia from oxidative stress-induced DNA damage and cell cycle arrest. J Pharmacol Sci 2005, 98(1):16-24.
172. Kim H., Kim Y.S., Kim S.Y., Suk K. The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production. Neurosci Lett 2001, 309(1):67-71.
173. Dell'Albani P., Santangelo R., Torrisi L., Nicoletti V.G., de Vellis J., Giuffrida Stella A.M. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J Neurosci Res 2001, 65(5):417-424.
174. Suk K., Lee H., Kang S.S., Cho G.J., Choi W.S. Flavonoid baicalein attenuates activation-induced cell death of brain microglia. J Pharmacol Exp Ther 2003, 305(2):638-645.
175. Spilsbury A., Vauzour D., Spencer J.P., Rattray M. Regulation of NF-κB activity in astrocytes: effects of flavonoids at dietary-relevant concentrations. Biochem Biophys Res Commun 2012, 418(3):578-583.
176. Michan S., Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007, 404(1):1-13.
177. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444(7117):337-342.
178. Knutson M.D., Leeuwenburgh C. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr Rev 2008, 66(10):591-596.
179. Baur J.A. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 2010, 131(4):261-269.
180. Park S.J., Ahmad F., Philp A., Baar K., Williams T., Luo H., et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148(3):421-433.
181. Tang B.L., Chua C.E. SIRT1 and neuronal diseases. Mol Aspects Med 2008, 29(3):187-200.
182. Parker J.A., Arango M., Abderrahmane S., Lambert E., Tourette C., Catoire H., et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 2005, 37(4):349-350.
183. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004, 23(12):2369-2380.
184. Vauzour D. Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev 2012, 2012:914273.